{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/06/24/3317171/0/en/Apollomics-Receives-Nasdaq-Deficiency-Notice-Regarding-Minimum-Market-Value-Requirement-and-Updates-Rights-for-Vebreltinib-APL-101-in-Asia.html", "message": "News view counter 815039 successfully enlarged"}